Liliana Di Nola Baron

Array ( [id] => 6788256 [patent_doc_number] => 20030139495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Polymer blends that swell in an acidic environment and deswell in a basic environment' [patent_app_type] => new [patent_app_number] => 10/327457 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7491 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20030139495.pdf [firstpage_image] =>[orig_patent_app_number] => 10327457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1234416 [patent_doc_number] => 06689345 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-10 [patent_title] => 'Care or make-up composition containing fibers and a hydrophilic polyoganosiloxane' [patent_app_type] => B2 [patent_app_number] => 10/251856 [patent_app_country] => US [patent_app_date] => 2002-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5883 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689345.pdf [firstpage_image] =>[orig_patent_app_number] => 10251856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1052901 [patent_doc_number] => 06858228 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-22 [patent_title] => 'Solid oral dosage forms of valsartan' [patent_app_type] => utility [patent_app_number] => 10/251009 [patent_app_country] => US [patent_app_date] => 2002-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4724 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/858/06858228.pdf [firstpage_image] =>[orig_patent_app_number] => 10251009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6678226 [patent_doc_number] => 20030228367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'LIQUID CRYSTALLINE POLYMERS' [patent_app_type] => new [patent_app_number] => 10/231723 [patent_app_country] => US [patent_app_date] => 2002-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 10853 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20030228367.pdf [firstpage_image] =>[orig_patent_app_number] => 10231723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6736006 [patent_doc_number] => 20030013641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Purification and stabilization of peptide and protein pharmaceutical agents' [patent_app_type] => new [patent_app_number] => 10/224761 [patent_app_country] => US [patent_app_date] => 2002-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7657 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013641.pdf [firstpage_image] =>[orig_patent_app_number] => 10224761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1260321 [patent_doc_number] => 06663852 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-16 [patent_title] => 'Method and makeup kit containing goniochromatic and monochromatic pigments' [patent_app_type] => B2 [patent_app_number] => 10/218405 [patent_app_country] => US [patent_app_date] => 2002-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4515 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/663/06663852.pdf [firstpage_image] =>[orig_patent_app_number] => 10218405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6773872 [patent_doc_number] => 20030017210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Microgranules containing cisplatin' [patent_app_type] => new [patent_app_number] => 10/200998 [patent_app_country] => US [patent_app_date] => 2002-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5163 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20030017210.pdf [firstpage_image] =>[orig_patent_app_number] => 10200998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1338573 [patent_doc_number] => 06586011 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-01 [patent_title] => 'Microencapsulated plasminogen activators' [patent_app_type] => B2 [patent_app_number] => 10/176294 [patent_app_country] => US [patent_app_date] => 2002-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5374 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586011.pdf [firstpage_image] =>[orig_patent_app_number] => 10176294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1175336 [patent_doc_number] => 06743439 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-01 [patent_title] => 'Ophthalmic compositions containing copolymers of sulfonated styrene and maleic anhydride' [patent_app_type] => B1 [patent_app_number] => 10/163114 [patent_app_country] => US [patent_app_date] => 2002-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2706 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/743/06743439.pdf [firstpage_image] =>[orig_patent_app_number] => 10163114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6744662 [patent_doc_number] => 20030021845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Gastroretentive controlled release pharmaceutical dosage forms' [patent_app_type] => new [patent_app_number] => 10/157325 [patent_app_country] => US [patent_app_date] => 2002-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9517 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 289 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20030021845.pdf [firstpage_image] =>[orig_patent_app_number] => 10157325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6536520 [patent_doc_number] => 20020193319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Use of EGF genistein to prevent development of EGF-receptor expressing cancers' [patent_app_type] => new [patent_app_number] => 10/145798 [patent_app_country] => US [patent_app_date] => 2002-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4735 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193319.pdf [firstpage_image] =>[orig_patent_app_number] => 10145798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786463 [patent_doc_number] => 20020160050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Melt granulated composition and modified release dosage form prepared from said composition' [patent_app_type] => new [patent_app_number] => 10/106805 [patent_app_country] => US [patent_app_date] => 2002-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3404 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160050.pdf [firstpage_image] =>[orig_patent_app_number] => 10106805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6178217 [patent_doc_number] => 20020156133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Oral administration forms for administering a fixed tramadol and diclofenac combination' [patent_app_type] => new [patent_app_number] => 10/016130 [patent_app_country] => US [patent_app_date] => 2001-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3890 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156133.pdf [firstpage_image] =>[orig_patent_app_number] => 10016130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1175425 [patent_doc_number] => 06743448 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-01 [patent_title] => 'Topical testosterone formulations and associated methods' [patent_app_type] => B2 [patent_app_number] => 10/021564 [patent_app_country] => US [patent_app_date] => 2001-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 17224 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/743/06743448.pdf [firstpage_image] =>[orig_patent_app_number] => 10021564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921188 [patent_doc_number] => 20020114837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Galenic composition for low bioavailability medicaments' [patent_app_type] => new [patent_app_number] => 10/015925 [patent_app_country] => US [patent_app_date] => 2001-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3514 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20020114837.pdf [firstpage_image] =>[orig_patent_app_number] => 10015925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6696318 [patent_doc_number] => 20030108512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the treatment of cancer' [patent_app_type] => new [patent_app_number] => 10/006197 [patent_app_country] => US [patent_app_date] => 2001-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11529 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20030108512.pdf [firstpage_image] =>[orig_patent_app_number] => 10006197 [rel_patent_id] =>[rel_patent_doc_number] =>)